Search
00
GBAF Logo
trophy
Top StoriesInterviewsBusinessFinanceBankingTechnologyInvestingTradingVideosAwardsMagazinesHeadlinesTrends

Subscribe to our newsletter

Get the latest news and updates from our team.

Global Banking & Finance Review®

Global Banking & Finance Review® - Subscribe to our newsletter

Company

    GBAF Logo
    • About Us
    • Profile
    • Privacy & Cookie Policy
    • Terms of Use
    • Contact Us
    • Advertising
    • Submit Post
    • Latest News
    • Research Reports
    • Press Release
    • Awards▾
      • About the Awards
      • Awards TimeTable
      • Submit Nominations
      • Testimonials
      • Media Room
      • Award Winners
      • FAQ
    • Magazines▾
      • Global Banking & Finance Review Magazine Issue 79
      • Global Banking & Finance Review Magazine Issue 78
      • Global Banking & Finance Review Magazine Issue 77
      • Global Banking & Finance Review Magazine Issue 76
      • Global Banking & Finance Review Magazine Issue 75
      • Global Banking & Finance Review Magazine Issue 73
      • Global Banking & Finance Review Magazine Issue 71
      • Global Banking & Finance Review Magazine Issue 70
      • Global Banking & Finance Review Magazine Issue 69
      • Global Banking & Finance Review Magazine Issue 66
    Top StoriesInterviewsBusinessFinanceBankingTechnologyInvestingTradingVideosAwardsMagazinesHeadlinesTrends

    Global Banking & Finance Review® is a leading financial portal and online magazine offering News, Analysis, Opinion, Reviews, Interviews & Videos from the world of Banking, Finance, Business, Trading, Technology, Investing, Brokerage, Foreign Exchange, Tax & Legal, Islamic Finance, Asset & Wealth Management.
    Copyright © 2010-2026 GBAF Publications Ltd - All Rights Reserved. | Sitemap | Tags | Developed By eCorpIT

    Editorial & Advertiser disclosure

    Global Banking & Finance Review® is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

    Home > Headlines > Hims and Hers to offer weight-loss treatments in UK
    Headlines

    Hims and Hers to offer weight-loss treatments in UK

    Published by Global Banking & Finance Review®

    Posted on December 10, 2025

    2 min read

    Last updated: January 20, 2026

    Hims and Hers to offer weight-loss treatments in UK - Headlines news and analysis from Global Banking & Finance Review
    Why waste money on news and opinion when you can access them for free?

    Take advantage of our newsletter subscription and stay informed on the go!

    Subscribe

    Tags:innovationhealthcareinsuranceweight loss

    Quick Summary

    Hims and Hers launches weight-loss treatments in the UK, offering drugs like Wegovy and Mounjaro at competitive prices through a subscription model.

    Hims and Hers Expands Weight-Loss Services to UK

    NEW YORK, ‌Dec 10 (Reuters) - Online telehealth company Hims and Hers Health is ‍launching ‌its weight-loss membership and treatment plans in the United Kingdom which will ⁠include drugs like Novo Nordisk's ‌Wegovy, the company said on Wednesday.

    The drug will be available at a starting price of 149 pounds ($198) a month for a year commitment.

    The company provides ⁠sexual health, skincare and hair loss treatments for men in the U.K. Earlier this year ​it bought Zava, a London-based company that prescribes and ‌delivers weight-loss drugs in the ⁠United Kingdom, Germany, France and Ireland.

    Hims' weight-loss program will also offer patients Eli Lilly's Mounjaro, in addition to Orlos, an older over-the-counter weight-loss ​drug with the generic name orlistat. Customers will access the drugs after a clinical assessment, Hims said in its release.

    Hims' U.K. model is similar to its offering in the U.S. where patients pay ​for ‍a subscription and as ​part of that receive a personalized prescription and clinical programming, such as follow-up visits related to their treatments.

    In the U.K., both Novo's and Lilly's drug cost far less than in the U.S., though access to them through the country's National Health Services has been limited.

    Lilly said in ⁠August it was raising the list price of Zepbound in the U.K. but the price was ​still expected to be less through online pharmacies which show prices for it and Novo's drugs of 109 pounds ($145) to 149 pounds ($198) per month.

    In the U.S., Lilly's Zepbound ranges from $299 ‌to $449 per month on its website while Novo's Wegovy costs from $199 per month to $349 on its site.

    (Reporting by Amina Niasse; editing by Caroline Humer)

    Key Takeaways

    • •Hims and Hers launches weight-loss plans in the UK.
    • •Includes drugs like Wegovy and Mounjaro.
    • •UK model similar to US subscription service.
    • •Drugs cost less in the UK than in the US.
    • •Hims acquired Zava for UK expansion.

    Frequently Asked Questions about Hims and Hers to offer weight-loss treatments in UK

    1What is a subscription model?

    A subscription model is a business strategy where customers pay a recurring fee to access a product or service, often providing ongoing support and updates.

    More from Headlines

    Explore more articles in the Headlines category

    Image for Southeast Poland's Lublin and Rzeszow airports closed due to 'unplanned military activity', US FAA says
    Southeast Poland's Lublin and Rzeszow airports closed due to 'unplanned military activity', US FAA says
    Image for Exclusive-US plans initial payment towards billions owed to UN-envoy Waltz
    Exclusive-US plans initial payment towards billions owed to UN-envoy Waltz
    Image for Trump says good talks ongoing on Ukraine
    Trump says good talks ongoing on Ukraine
    Image for France to rally aid for Lebanon as it warns truce gains remain fragile
    France to rally aid for Lebanon as it warns truce gains remain fragile
    Image for Exclusive-US aims for March peace deal in Ukraine, quick elections, sources say
    Exclusive-US aims for March peace deal in Ukraine, quick elections, sources say
    Image for Ukraine's Zelenskiy calls for faster action on air defence, repairs to grid
    Ukraine's Zelenskiy calls for faster action on air defence, repairs to grid
    Image for Olympics-Italy's president takes the tram in video tribute to Milan transport
    Olympics-Italy's president takes the tram in video tribute to Milan transport
    Image for Goldman Sachs teams up with Anthropic to automate banking tasks with AI agents, CNBC reports
    Goldman Sachs teams up with Anthropic to automate banking tasks with AI agents, CNBC reports
    Image for Analysis-Hims' $49 weight-loss pill rattles investor case for cash-pay obesity market
    Analysis-Hims' $49 weight-loss pill rattles investor case for cash-pay obesity market
    Image for Big Tech's quarter in four charts: AI splurge and cloud growth
    Big Tech's quarter in four charts: AI splurge and cloud growth
    Image for Exclusive-Bangladesh PM front-runner rejects unity government offer, says his party set to win
    Exclusive-Bangladesh PM front-runner rejects unity government offer, says his party set to win
    Image for Azerbaijan issues strong protest to Russia over lawmaker's comments on Karabakh trial
    Azerbaijan issues strong protest to Russia over lawmaker's comments on Karabakh trial
    View All Headlines Posts
    Previous Headlines PostRyanair loses challenge against Portuguese airline TAP's 2.55 billion euros state aid
    Next Headlines PostPoland could give Ukraine MiG jets in swap for drone tech